Recalls & Warnings July 04, 2017 FDA Warns Against Company's Unsafe Teething Tablets On June 20, 2017, the FDA issued a warning letter to Raritan Pharmaceuticals, Inc
The following drugs can cause some problems when taken together with Hydroxocobalamin Injection: chloramphenicol (an antibiotic) can reduce the effects of Hydroxocobalamin injection
Some less common but potentially more serious disorders including subarachnoid hemorrhage, intracranial mass lesions, cerebral vasculitis, and others can cause migraine-like symptoms
Future research utilizing metagenomics and transcriptomics could further elucidate catalpols role in diabetes and clarify the mechanisms underlying metabolic changes (Table 5
Nguyen, T., Thrift, A
Sinnamon JR, Jacobson ME, Yung JF, Fisk JR, Jeng S, McWeeney SK, et al